Working Together for Meaningful Progress

We share a bold goal with our partners: to end scleroderma. Progress depends on collaboration, and our work in 2025 with advocacy groups and industry leaders supports efforts to empower patients, inform researchers and clinicians, and advance scientific understanding of this complex disease.

Industry Partners

Amgen

Avalyn Pharma

Boehringer Ingelheim

Bristol Myers Squibb

Johnson & Johnson

Merck